CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-15 | ABERCROMBIE GEORGE B Director | Option exercise · Non-Qualified Stock Option | −5,000 | 5,000 | ||
| 2021-06-10 | Hutson Nancy J Director | Option exercise | +8,333 | $2.85 | $24K | 73,406 |
| 2021-06-10 | Hutson Nancy J Director | Option exercise | +15,000 | $3.32 | $50K | 88,406 |
| 2021-06-10 | Hutson Nancy J Director | Sale | −23,333 | $16.86 | $393K | 65,073 |
| 2021-06-10 | Hutson Nancy J Director | Option exercise · Non-Qualified Stock Option | −8,333 | 0 | ||
| 2021-06-10 | Hutson Nancy J Director | Option exercise · Automatic Stock Option Grant | −15,000 | 0 | ||
| 2021-05-28 | Sheridan William P Chief Medical Officer | Option exercise | +21,614 | $4.73 | $102K | 36,089 |
| 2021-05-28 | Sheridan William P Chief Medical Officer | Option exercise | +64,299 | $5.59 | $359K | 100,388 |
| 2021-05-28 | Sheridan William P Chief Medical Officer | Option exercise | +5,901 | $5.45 | $32K | 106,289 |
| 2021-05-28 | Sheridan William P Chief Medical Officer | Sale | −91,814 | $15.02 | $1.4M | 14,475 |
| 2021-05-28 | Sheridan William P Chief Medical Officer | Option exercise · Emp. Stock Option (Right to Buy) | −21,614 | 0 | ||
| 2021-05-28 | Sheridan William P Chief Medical Officer | Option exercise · Emp. Stock Option (Right to Buy) | −64,299 | 0 | ||
| 2021-05-28 | Sheridan William P Chief Medical Officer | Option exercise · Emp. Stock Option (Right to Buy) | −5,901 | 0 | ||
| 2021-05-28 | INGRAM ROBERT ALEXANDER Director | Grant or award | +1,188 | $15.77 | $19K | 76,201 |
| 2021-05-28 | Hutson Nancy J Director | Grant or award | +317 | $15.77 | $5K | 65,073 |
| 2021-05-28 | HEGGIE THERESA Director | Grant or award | +317 | $15.77 | $5K | 14,166 |
| 2021-05-28 | ASELAGE STEVE Director | Grant or award | +634 | $15.77 | $10K | 32,130 |
| 2021-05-27 | Sheridan William P Chief Medical Officer | Option exercise | +24,959 | $4.73 | $118K | 39,434 |
| 2021-05-27 | Sheridan William P Chief Medical Officer | Option exercise | +35,701 | $5.59 | $200K | 75,135 |
| 2021-05-27 | Sheridan William P Chief Medical Officer | Option exercise | +11,099 | $5.45 | $60K | 86,234 |
Page 21 of 27 · 522 trades